Osiris Therapeutics, Inc. (NASDAQ:OSIR)

CAPS Rating: 1 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Recs

0
Player Avatar edwardgs (< 20) Submitted: 4/23/2008 11:41:20 PM : Outperform Start Price: $11.75 OSIR Score: -46.51

medical

Featured Broker Partners


Advertisement